Further analysis of the anti-tumor effect of CXCL12 revealed that it was dependent on the presence of functional CD8+ T cells, in agreement with a previous study that demonstrated the importance of CD8+ T cells in CXCL12-mediated growth inhibition of melanoma and lung carcinoma [13]. This evidence concerns the gene CD8A and melanoma.